About Me
More info forI am a member of the Cancer Control Program at the OSUCCC – James, where my research focuses on the underlying mechanisms of cancer-induced behavioral comorbidities.
In particular, I use rodent models of breast cancer and cancer survival to study the immune-and endocrine-mediated effects of peripheral tumors on cognitive and affective-like behavior and associated changes in neurobiology.
I have co-authored numerous articles in well-respected publications, including Cancer and Brain, Behavior and Immunity.
Research Interests
More info for- Neoplasms
- Depression
- Wounds and Injuries
Academic Office & Contact Information
More info forAcademic Office:
Institute for Behavioral Medic
460 Medical Center Dr
Columbus, Ohio 43210-1229Phone:
614-293-3496Email:
pyter.1@osu.eduPublications
More info forMay 30, 2024Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer.
Otto-Dobos LD, Grant CV, Lahoud AA, Wilcox OR, Strehle LD, Loman BR, Adarkwah Yiadom S, Seng MM, Halloy N, Russart KLG, Carpenter KM, Dawson E, Sardesai SD, Williams NO, Gatti-Mays ME, Stover DG, Sudheendra PK, Wesolowski R, Kiecolt-Glaser JK, Bailey MT, Andridge RR, Pyter LM
Brain Behav Immun
January 31, 2024Microglia contribute to mammary tumor-induced neuroinflammation in a female mouse model.
Strehle LD, Otto-Dobos LD, Grant CV, Glasper ER, Pyter LM
FASEB J
January 1, 2024Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice.
Loman BR, Alzoubi Z, Lynch AJ, Jaggers RM, Jordan K, Grant CV, Rogers LK, Pyter LM, Bailey MT
Gut Microbes
April 21, 2023The role of microglia in 67NR mammary tumor-induced suppression of brain responses to immune challenges in female mice.
Otto-Dobos LD, Santos JC, Strehle LD, Grant CV, Simon LA, Oliver B, Godbout JP, Sheridan JF, Barrientos RM, Glasper ER, Pyter LM
J Neurochem
January 1, 2023Antibiotic treatment inhibits paclitaxel chemotherapy-induced activity deficits in female mice.
Grant CV, Jordan K, Seng MM, Pyter LM
PLoS One
March 5, 2022Mammary tumors alter the fecal bacteriome and permit enteric bacterial translocation.
Loman BR, Russart KLG, Grant CV, Lynch AJ, Bailey MT, Pyter LM
BMC Cancer
January 1, 2022Paclitaxel Chemotherapy Elicits Widespread Brain Anisotropy Changes in a Comprehensive Mouse Model of Breast Cancer Survivorship: Evidence From In Vivo Diffusion Weighted Imaging.
Otto LD, Russart KLG, Kulkarni P, McTigue DM, Ferris CF, Pyter LM
Front Oncol
November 19, 2021A novel targeted approach to delineate a role for estrogen receptor-β in ameliorating murine mammary tumor-associated neuroinflammation.
Grant CV, Russart KLG, Pyter LM
Endocrine
September 23, 2021Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in mice.
Sullivan KA, Grant CV, Jordan KR, Obrietan K, Pyter LM
Brain Behav Immun
August 18, 2021Tumor-Induced Cardiac Dysfunction: A Potential Role of ROS.
Karekar P, Jensen HN, Russart KLG, Ponnalagu D, Seeley S, Sanghvi S, Smith SA, Pyter LM, Singh H, Gururaja Rao S
Antioxidants (Basel)
December 3, 2020Voluntary wheel running ameliorates select paclitaxel chemotherapy-induced sickness behaviors and associated melanocortin signaling.
Sullivan KA, Grant CV, Jordan K, Vickery S, Pyter LM
Behav Brain Res